Virtu Financial LLC Zynerba Pharmaceuticals, Inc. Transaction History

Virtu Financial LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$0.33 - $1.39 $4,322 - $18,206	13,098 New	13,098 $17,000
Q1 2023 May 01, 2023	BUY	$0.4 - $0.67 $12,954 - $21,698	32,386 New	32,386 $14,000
Q3 2022 Nov 07, 2022	BUY	$0.87 - $1.36 $12,886 - $20,144	14,812 New	14,812 $11,000
Q4 2019 Feb 04, 2020	SELL	$5.61 - $8.57 $125,804 - $192,182	-22,425 Closed	0 $0
Q3 2019 Nov 20, 2019	BUY	$7.56 - $15.44 $169,533 - $346,242	22,425 New	22,425 $170,000
Q2 2019 Aug 13, 2019	SELL	$5.4 - $15.5 $120,873 - $346,952	-22,384 Closed	0 $0
Q1 2019 Apr 12, 2019	BUY	$3.6 - $6.22 $32,292 - $55,793	8,970 Added 66.87%	22,384 $121,000
Q4 2018 Jan 16, 2019	BUY	$2.89 - $7.91 $38,766 - $106,104	13,414 New	13,414 $40,000

774K

Ticker ZYNE
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 45,753,100
Description
Zynerba Pharmaceuticals, Inc. operates as a clinical stage specialty pharmaceutical company. The company focuses on developing pharmaceutically-produced transdermal cannabinoid therapies for rare and near-rare neuropsychiatric disorders. It is developing Zygel, a pharmaceutically-produced cannabidiol formulated as a permeation-enhanced gel for t...

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Virtu Financial LLC with notifications on news.